Should brands advertise beside health news?
Part of Fair publisher planning
The short answer
Brands can advertise beside health news when the reporting is responsible and the policy is written by topic and treatment, not by keyword. Coverage of outbreaks, research and public health guidance is journalism readers seek out. The risks sit elsewhere: misinformation that contradicts scientific consensus, graphic medical imagery and creative that reads as exploiting a crisis.
Key takeaways
- In 2020 coronavirus terms spread across keyword blocklists, and IAB UK publicly asked advertisers to stop blocking trusted pandemic news.
- Responsible health reporting can be recognized from its method: quantified risk, named sources with disclosed interests, and new findings placed in context.
- Misinformation is a separate category from disease coverage, and Google's publisher policies already bar monetizing content that contradicts authoritative scientific consensus during a major health crisis.
- The IAB Tech Lab Content Taxonomy splits Medical Health into topics such as Infectious Diseases and Vaccines, which lets a policy set different rules per topic.
- A good disease coverage clause names what stays in, what needs a look and what stays out, and pairs each with a creative rule.
Should brands advertise beside health news?
For an advertiser with a written policy, the answer can be yes. Health journalism covers what readers need to decide about their own lives: a new study on a common condition, a vaccine schedule change, a hospital closing, a local water advisory. Treating the whole subject as unsafe removes trusted publishers from a plan at the moments readers seek them out, and it moves budget toward pages that say less.
The useful question is not whether health news is safe but which health news fits which brand. A sunscreen maker beside skin cancer prevention reporting is a natural match. A snack brand beside a food recall story is not. A bank may be neutral to most medical research coverage but want distance from stories about patient deaths. The decision belongs to the brand, page by page and topic by topic, which is how the fair publisher planning hub frames sensitive but safe coverage in general.
| Kind of health story | Typical content | Starting position |
|---|---|---|
| Research and study coverage | New findings, trial results, expert reaction | In by default; review creative for implied health claims |
| Public health guidance | Vaccine schedules, screening advice, seasonal illness tips | In by default; a strong fit for wellness and household brands |
| Outbreak and disease tracking | Case counts, spread, local advisories | In with a look; avoid upbeat or urgent sale creative |
| Health system and policy news | Hospital funding, insurance rules, drug approvals | In by default; treat as policy news for political sensitivity |
| Patient deaths and medical harm | Fatal outcomes, malpractice, disaster casualties | Case by case for consumer brands |
Why was health news blocked during outbreaks?
Because keyword lists cannot tell a story about a disease from a disease itself. When COVID-19 spread in 2020, terms such as "coronavirus" went onto advertisers' keyword blocklists, so trusted pandemic reporting was filtered out along with every other page that used the word. The WHO (opens in a new tab) describes the same period's information problem as an infodemic: "too much information including false or misleading information in digital and physical environments during a disease outbreak."
The industry answered in public. IAB UK's advice to advertisers (opens in a new tab) told them to "Review your existing keyword blocklists to ensure that you are not including any coronavirus-related terms", to "enable advertising against hard news topics you may have previously been avoiding, including coronavirus", and to "Consider setting up direct relationships with news publishers to support their content at this time." The blocking pattern the guidance describes was not unique to one market, and the news blocklisting guide covers the measured effect of keyword lists on news more broadly.
How do you tell responsible health reporting from misinformation?
Read for method, not vocabulary. Health journalists have a published standard to measure against: the Association of Health Care Journalists Statement of Principles (opens in a new tab). It asks reporters to "Quantify the magnitude of the benefit or the risk in the story", to "Avoid vague, sensational language", to remember that "association is not cause", and to be "cautious in reporting results of preliminary studies, in vitro or animal studies." Pages that follow those habits are recognizably different from pages built to alarm or to sell.
| Signal | Responsible reporting | Warning sign |
|---|---|---|
| Risk | States how large a benefit or harm is, with the comparison | Says a food or drug "causes" or "cures" with no size given |
| Sources | Names researchers and discloses their funding or interests | Unnamed experts, or a single source with a product to sell |
| Study type | Says whether the study was in people, animals or a lab | Presents a lab result as advice for readers |
| Context | Places the finding within earlier evidence | Treats one study as overturning the consensus |
| Commerce | Editorial separated from advertising | The article ends in a link to buy the remedy it praises |
Platform rules already draw part of this line. Google's Unreliable and harmful claims policy (opens in a new tab) for publishers says Google does not allow content that "promotes harmful health claims, or relates to a current, major health crisis" and "contradicts authoritative scientific consensus", with examples such as "Anti-vaccine advocacy, denial of the existence of medical conditions such as AIDS or Covid-19, gay conversion therapy." Reporting about those claims, such as a story investigating a false cure, is a different page from one promoting it.
Which health topics need extra review?
A policy can only treat topics differently if it can name them. The IAB Tech Lab Content Taxonomy 3.1 (opens in a new tab) files health under Medical Health, with Tier 2 entries such as Diseases and Conditions, Medical Tests, Pharmaceutical Drugs, Surgery and Vaccines, and Tier 3 entries under Diseases and Conditions such as Infectious Diseases, Cancer and Lung and Respiratory Health. Those labels describe subject, not risk, so a policy adds its own review level on top.
Health topics that deserve a human look before approval
- Outbreak coverage with case or death counts, where creative tone matters more than the topic.
- Vaccine stories, where a brand should confirm the page reports evidence rather than campaigns against it.
- Pharmaceutical Drugs and treatment news, where an adjacent ad can read as an endorsement of a therapy.
- Surgery and medical imagery, where photos can cross from informative to graphic.
- Food safety and recall stories, for any food, drink or kitchen brand.
- Stories about named patients, where the page is about a person's suffering rather than a public health fact.
Some platform controls cover part of this ground, but only on some surfaces. Google's content suitability page (opens in a new tab), checked in October 2026, says excluded sensitive content categories such as tragedy and conflict apply to the Display Network and Google video partners, not to YouTube ads. A plan that relies on those switches for disease coverage on YouTube is relying on controls that do not reach it.
How should a policy treat disease coverage?
Write the clause before the next outbreak, in plain words a reviewer can apply in minutes. The best clauses separate three questions that keyword lists merge: what the page is about, how it treats the subject, and what the ad says. Each question gets its own rule, so a change in the news cycle changes only the review level, not the whole plan.
Five steps to a disease coverage clause
- Name the topics in. List research coverage, public health guidance and outbreak reporting from established newsrooms as eligible by default, using taxonomy labels so the list is consistent.
- Name the treatment out. Exclude pages that promote health claims against scientific consensus, sell remedies inside the article, or show graphic medical images.
- Set a look level for spikes. When a new outbreak dominates the news, move outbreak pages to human review for a fixed period rather than blocking them.
- Pair a creative rule. Keep urgent sale messages, humor and health benefit claims off outbreak and patient death pages, and keep neutral brand messages eligible.
- Record the exceptions. Log every page a reviewer removed or kept against the default, with the reason, so the clause can be tuned after the event.
Definition
- Disease coverage clause
- A section of a brand's suitability policy that sets which reporting about illness and outbreaks is eligible, which needs review and which is excluded, judged by the page's topic, its treatment of the subject and the ad's message.
How can PlacementGraph keep responsible health news in a plan?
What does a health news policy look like on a real brief?
Fictional example
A fictional regional grocery chain in Texas
A fictional grocery chain with stores in Houston, Dallas and San Antonio briefs a display plan for its pharmacy counters and seasonal flu shot clinics, in English and Spanish. The agency's inherited keyword list blocks "flu", "outbreak", "virus" and "hospital", which removes almost every page that discusses the season the campaign is about.
The planner replaces the list with a disease coverage clause. Public health guidance and vaccine schedule reporting from established Texas newsrooms and specialist health publishers become eligible by default. Outbreak tracking pages need a look during any week a new strain leads the news. Food recall stories stay out for the grocery creative but in for the pharmacy creative, which carries a neutral clinic message.
Pages promoting remedies against medical consensus are excluded on treatment, whatever words they use. The client signs off on the clause once, and later changes happen in the review level rather than the list.
Frequently asked questions
Is a press release about a new study the same as health news?
No. A release is written by the institution or company behind the study, while journalism weighs it against other evidence and outside sources. Pages that reprint releases with no added reporting deserve a closer look, particularly when the funder sells a related product. Judge them on the same method signals as any health article.
What if a health article was accurate when published but guidance later changed?
That is normal in medicine and not a sign of misinformation. Responsible publishers add update notes or dated corrections when guidance moves. A page that still presents old advice as current, with no date or note, is a weaker placement. Check publication and update dates during review rather than excluding older articles outright.
Should health news on a general news site be judged differently from a specialist health publisher?
Judge the page, then the site. A general newsroom's health desk can be as rigorous as a specialist outlet, and a specialist site can run thin, commercial articles. Read a sample of recent health pages from either kind of publisher and apply the same method signals before deciding the site's place on the list.
Can a food or drink brand appear beside outbreak coverage?
It can, with care over the specific story. Coverage of a respiratory virus is a different case for a beverage brand from a foodborne illness outbreak or a recall in its own category. Write that distinction into the policy so reviewers do not have to judge each case from scratch.
Sources
- COVID-19 x keyword blocking: 9 tips for advertisers (opens in a new tab)IAB UK
- Infodemic (opens in a new tab)World Health Organization
- Statement of Principles of the Association of Health Care Journalists (opens in a new tab)Association of Health Care Journalists
- Unreliable and harmful claims (opens in a new tab)Google Publisher Policies Help
- Content Taxonomy 3.1 (TSV) (opens in a new tab)IAB Tech Lab
- About content suitability (opens in a new tab)Google Ads Help
Researched and written by PlacementGraph Research. Read how we research, source and update these pages. Corrections: diana@placementgraph.com.